Company Profile

Company Description

This biopharmaceutical firm specializes in developing RNA interference (RNAi) therapies to treat diseases with genetic origins. Its innovative platform targets specific genes to silence disease-causing proteins, focusing on conditions like liver and cardiovascular disorders. The company collaborates with global partners to advance its pipeline, leveraging cutting-edge science to create transformative treatments for patients with unmet medical needs.